1-20 of 5135
Journal Articles
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PRMT5 inhibition reduces hyperinflammation in a murine model of secondary hemophagocytic lymphohistiocytosis

Open Access
Fiona Brown-Burke, Rachel Saadey, Hsiao-Yin Charlene Mao, Paola Marra, Eric Brooks, Alexa Wandtke, Ian Hout, Sydney Leon, Archisha Sharma, Aneeq Yasin, Taylor Cash, Elshafa Hassan Ahmed, Ethan Baiocchi, Stephanie Finoti, Xiaoli Zhang, Neha Bhagwat, Kris Vaddi, Peggy Scherle, Anna Mozhenkova, Ikbale El-Ayachi, Austin D. Schenk, Shelby L. Sloan, Kaylee Whitman, JoBeth Helmig-Mason, Sheldon Steyn, Haley L. Klimaszewski, Jessica Weist, Christoph Weigel, Shirsha Koirala, Lapo Alinari, Katiri Snyder, Parvathi Ranganathan, Chia-Jo Chen, Michael B. Jordan, Robert A. Baiocchi, Polina Shindiapina
Journal: Blood Advances
Blood Adv (2025) 9 (10): 2379–2392.
https://doi.org/10.1182/bloodadvances.2024013651
Published: 2025
Includes: Supplemental data
Journal Articles

What to do with the weight while preparing for CAR-T?

Open Access
Samuel J. Yates, Ishan Roy
Journal: Blood Advances
Blood Adv (2025) 9 (10): 2419–2421.
https://doi.org/10.1182/bloodadvances.2024015429
Published: 2025
Journal Articles

Glucagon-like peptide 1 receptor agonists and venous thromboembolism in type 2 diabetes: a target trial emulation

Open Access
Cho-Han Chiang, Junmin Song, Yu-Cheng Chang, Soravis Osataphan, Yu-Che Lee, Ko-Yun Chang, Kuan-Yu Chi, Cho-Hung Chiang, Anahita Dua, Leslie Lake, Mandy N. Lauw, Kenneth A. Bauer, Dhruv S. Kazi, Rushad Patell
Journal: Blood Advances
Blood Adv (2025) 9 (10): 2410–2418.
https://doi.org/10.1182/bloodadvances.2025015871
Published: 2025
Includes: Supplemental data
Journal Articles

Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in rhesus macaques

Open Access
Nicholas E. Petty, Stefan Radtke, Greta Kanestrom, Emily Fields, Olivier Humbert, Salvatore Fiorenza, Mallory J. Llewellyn, George S. Laszlo, Justin Thomas, Zach Burger, Kyle Swing, Haiying Zhu, Keith R. Jerome, Cameron J. Turtle, Roland B. Walter, Hans-Peter Kiem
Journal: Blood Advances
Blood Adv (2025) 9 (10): 2367–2378.
https://doi.org/10.1182/bloodadvances.2024015016
Published: 2025
Includes: Supplemental data
Journal Articles

ATM inhibition decreases ERK activation and is synergistic with ibrutinib in primary chronic lymphocytic leukemia cells

Open Access
Sara E. F. Kost, Ali Saleh, Jennifer Brown, Shek H. Yuan, Bozena Kuzio, Lin Yang, Versha Banerji, Spencer B. Gibson, James B. Johnston, Sachin Katyal
Journal: Blood Advances
Blood Adv (2025) 9 (10): 2422–2427.
https://doi.org/10.1182/bloodadvances.2024014407
Published: 2025
Includes: Supplemental data
Journal Articles

Rituximab for children with EBV-positive Burkitt lymphoma in East Africa

Open Access
William Frank Mawalla, Caroline Achola, Hadijah Nabalende, Isaac Otim, Ismail D. Legason, Martin D. Ogwang, Pamella M. Aol, Godlove Sandi, Hadija Mwamtemi, Salama Mahawi, Elifuraha Mkwizu, Philomena G. Lyamuya, Jacqueline P. Kamanga, Kristin Schroeder, Paul Ntemi, Clara Chamba, Dimitris Vavoulis, Liz Morrell, Lulu Chirande, Anna Schuh
Journal: Blood Advances
Blood Adv (2025) 9 (10): 2393–2401.
https://doi.org/10.1182/bloodadvances.2024015234
Published: 2025
Includes: Supplemental data
Journal Articles

Cytogenetic annotation automation in myelodysplastic syndrome research databases

Open Access
Samuel Urrutia, Kelly S. Chien, Ziyi Li, Alexandre Bazinet, Guilin Tang, Guillermo Garcia-Manero
Journal: Blood Advances
Blood Adv (2025) 9 (10): 2428–2430.
https://doi.org/10.1182/bloodadvances.2024015362
Published: 2025
Includes: Supplemental data
Journal Articles

The preclinical profile of SerpinPC: a potential new treatment for hemophilia

Open Access
James A. Huntington, Jill Reckless, Stéphanie G. I. Polderdijk, Patrick Hextall, Trevor P. Baglin
Journal: Blood Advances
Blood Adv (2025) 9 (10): 2402–2409.
https://doi.org/10.1182/bloodadvances.2024015201
Published: 2025
Includes: Supplemental data
Journal Articles

Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia

Open Access
Clinical Trials & Observations
Valentin Goede, Kirsten Fischer, Sandra Robrecht, Adam Giza, Martin J. S. Dyer, Michael J. Eckart, Lothar Mϋller, Lukáš Smolej, Nadine Kutsch, Anna-Maria Fink, Stephan Stilgenbauer, Michael Hallek
Journal: Blood Advances
Blood Adv (2025) 9 (10): 2431–2435.
https://doi.org/10.1182/bloodadvances.2024014875
Published: 2025
Includes: Supplemental data
Journal Articles

Breaking the cycle: PRMTs and secondary HLH relief

Open Access
Sakshi Malik, Shanmuganathan Chandrakasan
Journal: Blood Advances
Blood Adv (2025) 9 (10): 2436–2437.
https://doi.org/10.1182/bloodadvances.2025015863
Published: 2025
Journal Articles

Drug development for leukemia: comprehensive analysis of clinical trials from first report to drug approval

Open Access
Kellen Cristine Tjioe, Marisol Miranda Galvis, Kenza Mamouni, Thalyta Freitas, Muhannad Sharara, Brenda Santellano, Claudia Guillen, Jorge Cortes
Journal: Blood Advances
Blood Adv bloodadvances.2024014340.
https://doi.org/10.1182/bloodadvances.2024014340
Published: 2025
Includes: Supplemental data
Journal Articles

Response to "It might not be whether you get knocked down, but whether you..."

Open Access
Wei Ying Jen, Nicholas J Short
Journal: Blood Advances
Blood Adv bloodadvances.2025016766.
https://doi.org/10.1182/bloodadvances.2025016766
Published: 2025
Journal Articles

SGLT2i-associated erythrocytosis: Closing the evidence gap

Open Access
Benjamin Chin-Yee, Cyrus C. Hsia
Journal: Blood Advances
Blood Adv bloodadvances.2025016967.
https://doi.org/10.1182/bloodadvances.2025016967
Published: 2025
Journal Articles

Extramedullary Myeloma is Genomically Complex and Characterized by Near-Universal MAPK Pathway Alterations

Open Access
Saurabh Zanwar, Joseph Novak, Wilson I Gonsalves, Michael Howe, Esteban Braggio, S. Vincent Rajkumar, Moritz Binder, Dragan Jevremovic, Surendra Dasari, Shaji K Kumar
Journal: Blood Advances
Blood Adv bloodadvances.2025016619.
https://doi.org/10.1182/bloodadvances.2025016619
Published: 2025
Includes: Supplemental data
Journal Articles

Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT

Open Access
Clinical Trials & Observations
Shunto Kawamura, Daishi Nakagawa, Takashi Nagayama, Yuta Katayama, Noriko Doki, Wataru Takeda, Tetsuya Nishida, Ken-ichi Matsuoka, Takashi Ikeda, Hiroyuki Ohigashi, Masashi Sawa, Kentaro Fukushima, Junya Kanda, Kentaro Serizawa, Makoto Onizuka, Takahiro Fukuda, Yoshiko Atsuta, Yoshinobu Kanda, Hideki Nakasone
Journal: Blood Advances
Blood Adv (2025) 9 (9): 2356–2365.
https://doi.org/10.1182/bloodadvances.2024014408
Published: 2025
Includes: Supplemental data
Journal Articles

GVHD in the era of checkpoint inhibition in Hodgkin lymphoma

Open Access
Cecilia Anna Fidanza, Fabio Serpenti, Francesca Cavallaro, Kordelia Barbullushi, Nicolò Rampi, Francesca Gaia Rossi Dardanoni, Maria Goldaniga, Giorgia Natascia Saporiti, Francesco Passamonti
Journal: Blood Advances
Blood Adv (2025) 9 (9): 2341–2343.
https://doi.org/10.1182/bloodadvances.2025015912
Published: 2025
Journal Articles

Improved survival with model-based dosing of antithymocyte globulin in pediatric hematopoietic cell transplantation

Open Access
Clinical Trials & Observations
Rick Admiraal, Stefan Nierkens, Marc B. Bierings, Mirjam E. Belderbos, Alwin D. Huitema, Robbert G. M. Bredius, Yilin Jiang, Kevin J. Curran, Andromachi Scaradavou, Maria I. Cancio, Elizabeth Klein, Wouter J. Kollen, Dorine Bresters, Friso G. J. Calkoen, A. Birgitta Versluijs, C. Michel Zwaan, Jaap Jan Boelens, Caroline A. Lindemans
Journal: Blood Advances
Blood Adv (2025) 9 (9): 2344–2353.
https://doi.org/10.1182/bloodadvances.2024014836
Published: 2025
Includes: Supplemental data
Journal Articles

Is transplant success linked to donor CMV serostatus?

Open Access
Clinical Trials & Observations
Steven M. Devine
Journal: Blood Advances
Blood Adv (2025) 9 (9): 2354–2355.
https://doi.org/10.1182/bloodadvances.2025015934
Published: 2025
Journal Articles

Paudel BB, Tan S-F, Fox TE, et al. Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes. Blood Adv . 2024;8(5):1137-1142.

Open Access
Journal: Blood Advances
Blood Adv (2025) 9 (9): 2231.
https://doi.org/10.1182/bloodadvances.2025016279
Published: 2025
Includes: Supplemental data
Journal Articles

Taking a break: a therapeutic option for ECD?

Open Access
Matthias Papo, Kenneth McClain
Journal: Blood Advances
Blood Adv (2025) 9 (9): 2153–2154.
https://doi.org/10.1182/bloodadvances.2025015865
Published: 2025